Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1999;92(Suppl 37):35–40. doi: 10.1177/014107689909237s07

Diabetes in cystic fibrosis.

B Yung 1, M E Hodson 1
PMCID: PMC1297022  PMID: 10472251

Full text

PDF
35

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdul-Karim F. W., Dahms B. B., Velasco M. E., Rodman H. M. Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study. Arch Pathol Lab Med. 1986 Jul;110(7):602–606. [PubMed] [Google Scholar]
  2. Ahmad T., Nelson R., Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism. 1994 Feb;43(2):163–167. doi: 10.1016/0026-0495(94)90239-9. [DOI] [PubMed] [Google Scholar]
  3. Allen H. F., Gay E. C., Klingensmith G. J., Hamman R. F. Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S. Diabetes Care. 1998 Jun;21(6):943–948. doi: 10.2337/diacare.21.6.943. [DOI] [PubMed] [Google Scholar]
  4. Allen J. L. Progressive nephropathy in a patient with cystic fibrosis and diabetes. N Engl J Med. 1986 Sep 18;315(12):764–764. doi: 10.1056/NEJM198609183151215. [DOI] [PubMed] [Google Scholar]
  5. Arrigo T., Cucinotta D., Conti Nibali S., Di Cesare E., Di Benedetto A., Magazzù G., De Luca F. Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up. Acta Paediatr. 1993 Mar;82(3):249–253. doi: 10.1111/j.1651-2227.1993.tb12653.x. [DOI] [PubMed] [Google Scholar]
  6. Austin A., Kalhan S. C., Orenstein D., Nixon P., Arslanian S. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab. 1994 Jul;79(1):80–85. doi: 10.1210/jcem.79.1.8027259. [DOI] [PubMed] [Google Scholar]
  7. Couce M., O'Brien T. D., Moran A., Roche P. C., Butler P. C. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab. 1996 Mar;81(3):1267–1272. doi: 10.1210/jcem.81.3.8772610. [DOI] [PubMed] [Google Scholar]
  8. Cucinotta D., Arrigo T., De Luca F., Di Benedetto A., Lombardo F., Scoglio R., Sferlazzas C., Magazzù G. Metabolic and clinical events preceding diabetes mellitus onset in cystic fibrosis. Eur J Endocrinol. 1996 Jun;134(6):731–736. doi: 10.1530/eje.0.1340731. [DOI] [PubMed] [Google Scholar]
  9. Cucinotta D., Conti Nibali S., Arrigo T., Di Benedetto A., Magazzù G., Di Cesare E., Costantino A., Pezzino V., De Luca F. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res. 1990;34(1):33–38. doi: 10.1159/000181792. [DOI] [PubMed] [Google Scholar]
  10. Cucinotta D., De Luca F., Gigante A., Arrigo T., Di Benedetto A., Tedeschi A., Lombardo F., Romano G., Sferlazzas C. No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. Eur J Endocrinol. 1994 Mar;130(3):253–258. doi: 10.1530/eje.0.1300253. [DOI] [PubMed] [Google Scholar]
  11. De Luca F., Arrigo T., Conti Nibali S., Sferlazzas C., Gigante A., Di Cesare E., Cucinotta D. Insulin secretion, glycosylated haemoglobin and islet cell antibodies in cystic fibrosis children and adolescents with different degrees of glucose tolerance. Horm Metab Res. 1991 Oct;23(10):495–498. doi: 10.1055/s-2007-1003737. [DOI] [PubMed] [Google Scholar]
  12. De Luca F., Arrigo T., Di Benedetto A., Tedeschi A., Sferlazzas C., Crisafulli G., Di Cesare E., Romano G., Magazzù G., Cucinotta D. Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. Horm Res. 1995;44(2):45–50. doi: 10.1159/000184591. [DOI] [PubMed] [Google Scholar]
  13. Dodge J. A., Morrison G. Diabetes mellitus in cystic fibrosis: a review. J R Soc Med. 1992;85 (Suppl 19):25–28. [PMC free article] [PubMed] [Google Scholar]
  14. Dolan T. F., Jr Microangiopathy in a young adult with cystic fibrosis and diabetes mellitus. N Engl J Med. 1986 Apr 10;314(15):991–992. doi: 10.1056/NEJM198604103141514. [DOI] [PubMed] [Google Scholar]
  15. FitzSimmons S. C. The changing epidemiology of cystic fibrosis. J Pediatr. 1993 Jan;122(1):1–9. doi: 10.1016/s0022-3476(05)83478-x. [DOI] [PubMed] [Google Scholar]
  16. Frase L. L., Strickland A. D., Kachel G. W., Krejs G. J. Enhanced glucose absorption in the jejunum of patients with cystic fibrosis. Gastroenterology. 1985 Feb;88(2):478–484. doi: 10.1016/0016-5085(85)90510-4. [DOI] [PubMed] [Google Scholar]
  17. Geffner M. E., Lippe B. M., Kaplan S. A., Itami R. M., Gillard B. K., Levin S. R., Taylor I. L. Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function. Pediatr Res. 1984 Nov;18(11):1107–1111. doi: 10.1203/00006450-198411000-00011. [DOI] [PubMed] [Google Scholar]
  18. Geffner M. E., Lippe B. M., Maclaren N. K., Riley W. J. Role of autoimmunity in insulinopenia and carbohydrate derangements associated with cystic fibrosis. J Pediatr. 1988 Mar;112(3):419–421. doi: 10.1016/s0022-3476(88)80324-x. [DOI] [PubMed] [Google Scholar]
  19. Hamdi I., Payne S. J., Barton D. E., McMahon R., Green M., Shneerson J. M., Hales C. N. Genotype analysis in cystic fibrosis in relation to the occurrence of diabetes mellitus. Clin Genet. 1993 Apr;43(4):186–189. doi: 10.1111/j.1399-0004.1993.tb04445.x. [DOI] [PubMed] [Google Scholar]
  20. Hardin D. S., LeBlanc A., Lukenbough S., Seilheimer D. K. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr. 1997 Jun;130(6):948–956. doi: 10.1016/s0022-3476(97)70282-8. [DOI] [PubMed] [Google Scholar]
  21. Hodson M. E. Diabetes mellitus and cystic fibrosis. Baillieres Clin Endocrinol Metab. 1992 Oct;6(4):797–805. doi: 10.1016/s0950-351x(05)80166-1. [DOI] [PubMed] [Google Scholar]
  22. Holl R. W., Buck C., Cario H., Wolf A., Thon A., Kohne E., Debatin K. M. Diagnosis of diabetes in cystic fibrosis and thalassemia major. Diabetes Care. 1998 Apr;21(4):671–672. doi: 10.2337/diacare.21.4.671. [DOI] [PubMed] [Google Scholar]
  23. Iannucci A., Mukai K., Johnson D., Burke B. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol. 1984 Mar;15(3):278–284. doi: 10.1016/s0046-8177(84)80191-4. [DOI] [PubMed] [Google Scholar]
  24. Kerem E., Corey M., Kerem B. S., Rommens J., Markiewicz D., Levison H., Tsui L. C., Durie P. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med. 1990 Nov 29;323(22):1517–1522. doi: 10.1056/NEJM199011293232203. [DOI] [PubMed] [Google Scholar]
  25. Kopito L. E., Shwachman H. The pancreas in cystic fibrosis: chemical composition and comparative morphology. Pediatr Res. 1976 Aug;10(8):742–749. doi: 10.1203/00006450-197608000-00010. [DOI] [PubMed] [Google Scholar]
  26. Kristidis P., Bozon D., Corey M., Markiewicz D., Rommens J., Tsui L. C., Durie P. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet. 1992 Jun;50(6):1178–1184. [PMC free article] [PubMed] [Google Scholar]
  27. Lanng S. Diabetes mellitus in cystic fibrosis. Eur J Gastroenterol Hepatol. 1996 Aug;8(8):744–747. [PubMed] [Google Scholar]
  28. Lanng S., Hansen A., Thorsteinsson B., Nerup J., Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ. 1995 Sep 9;311(7006):655–659. doi: 10.1136/bmj.311.7006.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lanng S., Thorsteinsson B., Lund-Andersen C., Nerup J., Schiøtz P. O., Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr. 1994 Jan;83(1):72–77. doi: 10.1111/j.1651-2227.1994.tb12956.x. [DOI] [PubMed] [Google Scholar]
  30. Lanng S., Thorsteinsson B., Lund-Andersen C., Nerup J., Schiøtz P. O., Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr. 1994 Jan;83(1):72–77. doi: 10.1111/j.1651-2227.1994.tb12956.x. [DOI] [PubMed] [Google Scholar]
  31. Lanng S., Thorsteinsson B., Nerup J., Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr. 1994 Aug;83(8):849–853. doi: 10.1111/j.1651-2227.1994.tb13156.x. [DOI] [PubMed] [Google Scholar]
  32. Lanng S., Thorsteinsson B., Pociot F., Marshall M. O., Madsen H. O., Schwartz M., Nerup J., Koch C. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr. 1993 Feb;82(2):150–154. doi: 10.1111/j.1651-2227.1993.tb12628.x. [DOI] [PubMed] [Google Scholar]
  33. Lanng S., Thorsteinsson B., Røder M. E., Nerup J., Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol (Oxf) 1994 Aug;41(2):217–223. doi: 10.1111/j.1365-2265.1994.tb02533.x. [DOI] [PubMed] [Google Scholar]
  34. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul;28(7):412–419. doi: 10.1007/BF00280883. [DOI] [PubMed] [Google Scholar]
  35. Mogensen C. E., Keane W. F., Bennett P. H., Jerums G., Parving H. H., Passa P., Steffes M. W., Striker G. E., Viberti G. C. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet. 1995 Oct 21;346(8982):1080–1084. doi: 10.1016/s0140-6736(95)91747-0. [DOI] [PubMed] [Google Scholar]
  36. Moran A., Diem P., Klein D. J., Levitt M. D., Robertson R. P. Pancreatic endocrine function in cystic fibrosis. J Pediatr. 1991 May;118(5):715–723. doi: 10.1016/s0022-3476(05)80032-0. [DOI] [PubMed] [Google Scholar]
  37. Moran A., Pyzdrowski K. L., Weinreb J., Kahn B. B., Smith S. A., Adams K. S., Seaquist E. R. Insulin sensitivity in cystic fibrosis. Diabetes. 1994 Aug;43(8):1020–1026. doi: 10.2337/diab.43.8.1020. [DOI] [PubMed] [Google Scholar]
  38. Reisman J., Corey M., Canny G., Levison H. Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics. 1990 Sep;86(3):374–377. [PubMed] [Google Scholar]
  39. Robert J. J., Grasset E., de Montalembert M., Chevenne D., Deschamps I., Boitard C., Lenoir G. Recherche de facteurs d'intolérance au glucose dans la mucoviscidose. Arch Fr Pediatr. 1992 Jan;49(1):17–22. [PubMed] [Google Scholar]
  40. Rodman H. M., Doershuk C. F., Roland J. M. The interaction of 2 diseases: diabetes mellitus and cystic fibrosis. Medicine (Baltimore) 1986 Nov;65(6):389–397. doi: 10.1097/00005792-198611000-00004. [DOI] [PubMed] [Google Scholar]
  41. Rosenecker J., Eichler I., Kühn L., Harms H. K., von der Hardt H. Genetic determination of diabetes mellitus in patients with cystic fibrosis. Multicenter Cystic Fibrosis Study Group. J Pediatr. 1995 Sep;127(3):441–443. doi: 10.1016/s0022-3476(95)70080-3. [DOI] [PubMed] [Google Scholar]
  42. SHWACHMAN H., LEUBNER H., CATZEL P. Mucoviscidosis. Adv Pediatr. 1955;7:249–323. [PubMed] [Google Scholar]
  43. Soejima K., Landing B. H. Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr Pathol. 1986;6(1):25–46. doi: 10.3109/15513818609025923. [DOI] [PubMed] [Google Scholar]
  44. Stutchfield P. R., O'Halloran S., Teale J. D., Isherwood D., Smith C. S., Heaf D. Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child. 1987 Aug;62(8):805–810. doi: 10.1136/adc.62.8.805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sullivan M. M., Denning C. R. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics. 1989 Oct;84(4):642–647. [PubMed] [Google Scholar]
  46. Taylor C. J., Baxter P. S., Hardcastle J., Hardcastle P. T., Goldhill J. Glucose intolerance in cystic fibrosis. Arch Dis Child. 1989 May;64(5):759–759. doi: 10.1136/adc.64.5.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wareham N. J., O'Rahilly S. The changing classification and diagnosis of diabetes. New classification is based on pathogenesis, not insulin dependence. BMJ. 1998 Aug 8;317(7155):359–360. doi: 10.1136/bmj.317.7155.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wareham N. J., Phillips D. I., Byrne C. D., Hales C. N. The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med. 1995 Oct;12(10):931–931. doi: 10.1111/j.1464-5491.1995.tb00399.x. [DOI] [PubMed] [Google Scholar]
  49. Yung B., Kemp M., Hooper J., Hodson M. E. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax. 1999 Jan;54(1):40–43. doi: 10.1136/thx.54.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Yung B., Kemp M., Hooper J., Hodson M. Random blood glucose alone in the diagnosis of cystic fibrosis related diabetes. Lancet. 1997 Mar 1;349(9052):619–619. doi: 10.1016/S0140-6736(05)61566-8. [DOI] [PubMed] [Google Scholar]
  51. Yung B., Landers A., Mathalone B., Gyi K. M., Hodson M. E. Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes. Respir Med. 1998 Jun;92(6):871–872. doi: 10.1016/s0954-6111(98)90390-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES